|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-9-3
|
|
pubmed:abstractText |
To quantify changes of bone marrow microcirculation in multiple myeloma (MM) using contrast enhanced dynamic MRI (dMRI) during thalidomide as antiangiogenic monotherapy or in combination with chemotherapy (cyclophosphamide, etoposide, dexamethasone).
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1438-9029
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
176
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1285-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15346264-Administration, Oral,
pubmed-meshheading:15346264-Adult,
pubmed-meshheading:15346264-Aged,
pubmed-meshheading:15346264-Angiogenesis Inhibitors,
pubmed-meshheading:15346264-Antineoplastic Agents, Alkylating,
pubmed-meshheading:15346264-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15346264-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:15346264-Bone Marrow,
pubmed-meshheading:15346264-Cyclophosphamide,
pubmed-meshheading:15346264-Data Interpretation, Statistical,
pubmed-meshheading:15346264-Dexamethasone,
pubmed-meshheading:15346264-Drug Therapy, Combination,
pubmed-meshheading:15346264-Etoposide,
pubmed-meshheading:15346264-Female,
pubmed-meshheading:15346264-Follow-Up Studies,
pubmed-meshheading:15346264-Humans,
pubmed-meshheading:15346264-Infusions, Intravenous,
pubmed-meshheading:15346264-Magnetic Resonance Imaging,
pubmed-meshheading:15346264-Male,
pubmed-meshheading:15346264-Microcirculation,
pubmed-meshheading:15346264-Middle Aged,
pubmed-meshheading:15346264-Multiple Myeloma,
pubmed-meshheading:15346264-Prospective Studies,
pubmed-meshheading:15346264-Remission Induction,
pubmed-meshheading:15346264-Thalidomide,
pubmed-meshheading:15346264-Time Factors,
pubmed-meshheading:15346264-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy].
|
|
pubmed:affiliation |
Abteilung Onkologische Diagnostik und Therapie, Deutsches Krebsforschungszentrum, Heidelberg. k.wasser@dkfz.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Controlled Clinical Trial
|
